🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Ciclesonide HFA

Found 12 matching trials

Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)

PHASE3

The primary objective of this study is to demonstrate that there are no cli...

Status

Completed

Location

Altana/Nycomed

Start Date

2004-12

Trial ID

NCT00659048

Treatments Being Tested

Ciclesonide Placebo

A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma

PHASE3

The purpose of this study is to investigate the efficacy of inhaled cicleso...

Status

Completed

Location

Altana Pharma/Nycomed

Start Date

2006-09

Trial ID

NCT00384189

Treatments Being Tested

Ciclesonide Placebo Salbutamol

Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older

PHASE3

This clinical research study will evaluate the safety and effectiveness of ...

Status

Completed

Location

Allergy and Asthma Associates

Start Date

2009-12

Trial ID

NCT01010971

Treatments Being Tested

Ciclesonide HFA 160 μg Ciclesonide HFA 80 μg Placebo

Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)

PHASE4

The purpose of this study is to compare the systemic des-ciclesonide exposu...

Status

Completed

Location

ALTANA Pharma

Start Date

2007-04

Trial ID

NCT00458835

Treatments Being Tested

Ciclesonide

Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis

PHASE3

This is an open-label, randomized, multicenter, 2-way crossover study in su...

Status

Completed

Location

Allergy and Asthma Associates of Southern California

Start Date

2011-02

Trial ID

NCT01287364

Treatments Being Tested

ciclesonide hydrofluoroalkane (HFA) nasal aerosol mometasone nasal inhalation

Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)

PHASE2

The primary objective of this study is to demonstrate the efficacy of cicle...

Status

Completed

Location

Altana/Nycomed

Start Date

2007-04

Trial ID

NCT00807053

Treatments Being Tested

Ciclesonide HFA Ciclesonide HFA Ciclesonide HFA Placebo

Individualizing Treatment for Asthma in Primary Care

PHASE4

This is a patient level randomized trial for teenagers and adults with asth...

Status

Completed

Location

DARTNet Insitute

Start Date

2024-02-01

Trial ID

NCT06272370

Treatments Being Tested

Asthma Symptom Monitoring online tools Inhaled Steroids Azithromycin Pill

Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis

PHASE3

To demonstrate the effects of ciclesonide applied as a nasal aerosol and ci...

Status

Completed

Location

Clinical Research Atlanta

Start Date

2010-01

Trial ID

NCT01033825

Treatments Being Tested

Ciclesonide HFA Nasal Aerosol 320 mcg Ciclesonide HFA Nasal Aerosol 160 mcg HFA Nasal Aerosol placebo Ciclesonide Aqueous Nasal Spray 200 mcg AQ Nasal Spray Placebo Placebo plus Dexamethasone HFA Placebo AQ plus Dexamethasone 6 mg

A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

PHASE3

This is a 6-month multi-center, randomized, double-blind, placebo-controlle...

Status

Completed

Location

Asthma and Allergy Specialists Medical Group

Start Date

2009-08

Trial ID

NCT00953147

Treatments Being Tested

Ciclesonide HFA 80 mcg Ciclesonide HFA 160 mcg Placebo

A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

PHASE3

6-month safety extension study in subjects who have completed Study 060-633...

Status

Completed

Location

Allergy and Asthma Specialists Group

Start Date

2010-02

Trial ID

NCT01067105

Treatments Being Tested

ciclesonide HFA 160 μg

Previous Next